Metrics as of 10/13/2026, 06:41 PM (Berlin time), refresh in progress.
iRhythm Technologies Stock
iRhythm Technologies, Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- United States
- CEO
- Quentin S. Blackford
- Employees
- 2,400
- Market cap
- $3.5 B
- IPO
- 20/10/2016
iRhythm Technologies, Inc. is a digital healthcare enterprise headquartered in San Francisco, USA, that specializes in portable electrocardiogram (ECG) monitoring solutions. The company's primary offering is the Zio service, which provides a comprehensive ambulatory cardiac monitoring system. This system combines…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
iRhythm Technologies stock: price history
1D
+0.4%
1W
-0.1%
1M
-3.9%
6M
-13.1%
YTD
-39.6%
1Y
-39.6%
2Y
+87.6%
5Y
+69.4%
10Y
–
Next earnings date
Next earnings date
29/10/2026 (in 12 days)
Volatility around earnings
~63% stronger price swings than usual
Ask the agents about iRhythm Technologies
Analyst assessment of iRhythm Technologies
PRICE TARGET LOW
US$160.00
CONSENSUS
US$174.88
MEDIAN
US$168.00
PRICE TARGET HIGH
US$196.00
0
STRONG BUY
18
BUY
3
HOLD
0
SELL
0
STRONG SELL
21
TOTAL · Buy
As of: 06/10/2026
iRhythm Technologies stock metrics
P/E
-248.86
P/B
18.93
EV/EBITDA
148.84
RETURN ON EQUITY
-0.2%
NET MARGIN
-0.2%
DEBT/EQUITY
3.91
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
93.7%
FLOAT SHARES
30,793,062
AVG. DAILY VOLUME (30D)
509,799
Insider transactions (SEC)
Wilson Daniel G.
Blackford Quentin S.
Turakhia Minang
Turakhia Minang
Shrishrimal Sumi
Institutional holders
Comparable stocks
Frequently asked questions about iRhythm Technologies stock
What does iRhythm Technologies do?
iRhythm Technologies, Inc. is a company in the Healthcare sector, Medical - Devices industry, headquartered in United States.
The CEO is Quentin S. Blackford, the company employs around 2,400 people.
The IPO was on 20/10/2016; the stock trades on NASDAQ under the ticker IRTC.
What do analysts say about iRhythm Technologies stock?
21 analysts rate the stock, the consensus is Buy (as of 06/10/2026).
The average price target is US$174.88, ranging from US$160.00 to US$196.00, with a median of US$168.00.
This is an external assessment, not a statement by Market Jury.
When does iRhythm Technologies report next?
The next earnings date is 29/10/2026.
Around past earnings, price swings were roughly 63% stronger than usual.
Does iRhythm Technologies pay a dividend?
No, iRhythm Technologies currently does not pay a dividend.
Which stocks are comparable to iRhythm Technologies?
Comparable stocks include Abbott Laboratories, Stryker, Boston Scientific, Edwards Lifesciences, DexCom, GE HealthCare Technologies, Zimmer Biomet Holdings and Align Technology.
How can I get iRhythm Technologies stock analyzed?
Clicking "Analyze stock" lets five strategies assess iRhythm Technologies against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.